The Evolution in Nomenclature, Diagnosis, and Classification of Pulmonary Hypertension

Jan Fouad; Phillip Joseph

doi:10.1016/j.ccm.2020.11.012

The Evolution in Nomenclature, Diagnosis, and Classification of Pulmonary Hypertension

Clin Chest Med. 2021 Mar;42(1):1-8. doi: 10.1016/j.ccm.2020.11.012. Epub 2021 Jan 8.

Authors

Jan Fouad¹, Phillip Joseph²

Affiliations

¹ Pulmonary, Critical Care, and Sleep Medicine, Yale New Haven Hospital/Yale School of Medicine, 300 Cedar Street, New Haven, CT 06520, USA.
² Pulmonary, Critical Care, and Sleep Medicine, Yale New Haven Hospital/Yale School of Medicine, 20 York Street, New Haven, CT 06519, USA. Electronic address: phillip.joseph@yale.edu.

PMID: 33541603
DOI: 10.1016/j.ccm.2020.11.012

Abstract

The current description of pulmonary hypertension is a testament to the physicians and scientists who dedicated their lives to furthering understanding of the pulmonary circulation. This has spanned a millennium, from ancient Egyptian descriptions of human anatomy to the current molecular and hemodynamic phenotyping of pulmonary hypertension. The recent Sixth World Symposium on Pulmonary Hypertension is a direct result of these discoveries and reflects an evolution in a classification scheme that has spanned half a century. This provides a framework for future directions related to therapeutics and mechanisms of disease.

Keywords: Classification; Diagnosis; Nomenclature; Pulmonary hypertension.

Publication types

Review

MeSH terms

Humans
Hypertension, Pulmonary* / classification
Hypertension, Pulmonary* / diagnosis
Terminology as Topic*